These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 3930554)

  • 1. Hyperthyroidism influences the distribution and apolipoprotein A composition of the high density lipoproteins in man.
    Muls E; Rosseneu M; Bury J; Stul M; Lamberigts G; De Moor P
    J Clin Endocrinol Metab; 1985 Nov; 61(5):882-9. PubMed ID: 3930554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the distribution and composition of high-density lipoproteins in primary hypothyroidism.
    Muls E; Rosseneu M; Lamberigts G; De Moor P
    Metabolism; 1985 Apr; 34(4):345-53. PubMed ID: 3920475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipids and apolipoproteins A-I, A-II, and B in hyperthyroidism before and after treatment.
    Muls E; Blaton V; Rosseneu M; Lesaffre E; Lamberigts G; De Moor P
    J Clin Endocrinol Metab; 1982 Sep; 55(3):459-64. PubMed ID: 6808006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial apolipoprotein AI and apolipoprotein CIII deficiency. Subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosis.
    Forte TM; Nichols AV; Krauss RM; Norum RA
    J Clin Invest; 1984 Nov; 74(5):1601-13. PubMed ID: 6501564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
    Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
    J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein and lipid composition of plasma lipoproteins in neonates during the first month of life.
    van Biervliet JP; Rosseneu M; Bury J; Caster H; Stul MS; Lamote R
    Pediatr Res; 1986 Apr; 20(4):324-8. PubMed ID: 3085061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effects of prednisone on serum lipids and high density lipoprotein subfractions in normolipidemic healthy men.
    Taskinen MR; Kuusi T; Yki-Järvinen H; Nikkilä EA
    J Clin Endocrinol Metab; 1988 Aug; 67(2):291-9. PubMed ID: 3134387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of gemfibrozil on lipoprotein metabolism.
    Saku K; Gartside PS; Hynd BA; Kashyap ML
    J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.
    Zhang B; Tomura H; Kuwabara A; Kimura T; Miura S; Noda K; Okajima F; Saku K
    Atherosclerosis; 2005 Jan; 178(1):199-205. PubMed ID: 15585219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of "light'-HDL during partial recovery.
    Weidman SW; Ragland JB; Sabesin SM
    J Lipid Res; 1982 May; 23(4):556-69. PubMed ID: 7097121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of total parenteral nutrition with intravenous fat on lipids and high density lipoprotein heterogeneity in neonates.
    Forte TM; Genzel-Boroviczeny O; Austin MA; Kao LC; Scott C; Albers JJ; D'Harlingue AE
    JPEN J Parenter Enteral Nutr; 1989; 13(5):490-500. PubMed ID: 2514290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ; van Gent CM; Buytenhek R; Buis B
    J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between apolipoprotein C-III concentrations and high-density lipoprotein subclass distribution.
    Tian L; Wu J; Fu M; Xu Y; Jia L
    Metabolism; 2009 May; 58(5):668-74. PubMed ID: 19375590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between plasma lipid concentrations and HDL subclasses.
    Yang Y; Yan B; Fu M; Xu Y; Tian Y
    Clin Chim Acta; 2005 Apr; 354(1-2):49-58. PubMed ID: 15748599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical studies on lipid metabolism in hyperthyroidism and hypothyroidism--evaluation of serum apolipoprotein levels before and after treatment].
    Oribe H
    Nihon Naibunpi Gakkai Zasshi; 1989 Aug; 65(8):781-93. PubMed ID: 2509259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in serum lipoprotein(a) and lipids during treatment of hyperthyroidism.
    Kung AW; Pang RW; Lauder I; Lam KS; Janus ED
    Clin Chem; 1995 Feb; 41(2):226-31. PubMed ID: 7874776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipoprotein and apolipoprotein concentrations in patients with hyperthyroidism and the effect of treatment with carbimazole.
    Boberg J; Dahlberg PA; Vessby B; Lithell H
    Acta Med Scand; 1984; 215(5):453-9. PubMed ID: 6588732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.